These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 526402)

  • 61. A long-term study of labetalol in general practice.
    Kane J; Gregg I; Stephens MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):167S-170S. PubMed ID: 118766
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A; Ziacchi V; Lomanto B
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):438-45. PubMed ID: 6754634
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of labetalol and chlorthalidone on exercise tolerance in hypertensive subjects].
    Raffo M; Cherchi A; Sau F; Pirisi R; Seguro C; Pisano MR
    Boll Soc Ital Cardiol; 1979; 24(6):657-66. PubMed ID: 551798
    [No Abstract]   [Full Text] [Related]  

  • 64. Effects of long-term high-dose labetalol on blood pressure in patients with severe hypertension resistant to previous therapy.
    Kristensen BO; la Cour Petersen E
    Postgrad Med J; 1980; 56 Suppl 2():57-9. PubMed ID: 7433344
    [No Abstract]   [Full Text] [Related]  

  • 65. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
    Mehta J; Cohn JN
    Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Effects of prolonged treatment with labetalol on renal function and on water and saline metabolism in essential and reno-parenchymal hypertension].
    Valvo E; Tessitore N; Previato G; Lupo A; Lo Schiavo C; Tornieri G; Maschio G
    Minerva Nefrol; 1979; 26(1):1-3. PubMed ID: 471316
    [No Abstract]   [Full Text] [Related]  

  • 67. Systemic and coronary hemodynamic effects of combined alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress test responses.
    Prida XE; Hill JA; Feldman RL
    Am J Cardiol; 1987 May; 59(12):1084-8. PubMed ID: 2883869
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Labetalol in the difficult hypertensive patient in general practice.
    Harris C
    Curr Med Res Opin; 1978; 5(8):618-24. PubMed ID: 710176
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Sep; 2(3):369-76. PubMed ID: 3154919
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of hypertension following endotracheal intubation. A study comparing the efficacy of labetalol, practolol and placebo.
    Maharaj RJ; Thompson M; Brock-Utne JG; Williamson R; Downing JW
    S Afr Med J; 1983 Apr; 63(18):691-4. PubMed ID: 6342168
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Intravenous labetalol in the management of severe hypertension and hypertensive emergencies.
    Cressman MD; Vidt DG; Gifford RW; Moore WS; Wilson DJ
    Am Heart J; 1984 May; 107(5 Pt 1):980-5. PubMed ID: 6720529
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients.
    Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():279s-281s. PubMed ID: 282068
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Labetalol in essential hypertension.
    Breckenridge A; Orme M; Serlin MJ; Maciver M
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):37S-39S. PubMed ID: 6124264
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
    Stern N; Teicher A; Rosenthal T
    Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labetalol and 24-hour monitoring of arterial blood pressure in hypertensive patients.
    Ferrari A; Buccino N; Di Rienzo M; Pedotti A; Mancia G; Zanchetti A
    J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S42-52. PubMed ID: 6169959
    [No Abstract]   [Full Text] [Related]  

  • 76. Rapid reduction of blood pressure with acute oral labetalol.
    Davies AB; Bala Subramanian V; Gould B; Raftery EB
    Br J Clin Pharmacol; 1982 May; 13(5):705-10. PubMed ID: 7082539
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Labetalol in the treatment of a patient with phaechromocytoma: a case report.
    Bailey RR
    Br J Clin Pharmacol; 1979; 8(Suppl 2):141S-142S. PubMed ID: 526394
    [No Abstract]   [Full Text] [Related]  

  • 78. A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.
    Dawson A; Johnson BF; Smith IK; Munro-Faure AD
    Br J Clin Pharmacol; 1979 Aug; 8(2):149-54. PubMed ID: 385023
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of hypertension in the elderly with labetalol.
    Eisalo A; Virta P
    Acta Med Scand Suppl; 1982; 665():129-33. PubMed ID: 6961759
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Labetalol in resistant hypertension.
    Hedstrand H
    Acta Med Scand Suppl; 1982; 665():125-8. PubMed ID: 6961758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.